Celcarb 150mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Carboplatin (150mg)
Overview Celcarb 150mg Injection
Carbicel 150mg Injection treats ovarian and small cell lung cancers by inhibiting or reducing cancerous cell proliferation. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue use only under physician guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding or bruising, or dark urine immediately. Regular blood tests monitoring blood cell counts, heart, liver function, and uric acid levels are necessary. Report any allergic reactions like skin rash, itching, or breathing difficulties. Inform your healthcare provider of all medications you're taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is essential throughout treatment.
Primary Ingredients of Celcarb 150mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Celcarb 150mg Injection
Cancers of the ovary and lung (small cell type)
Major Benefits of Celcarb 150mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Celcarb 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Celcarb 150mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Celcarb 150mg Injection works:
Oncolytic injection Celcarb, 150mg, is an anti-neoplastic agent. Its mechanism of action involves disrupting the cancerous cells' DNA and RNA, thereby inhibiting proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Celcarb 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Celcarb 150mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in exceptional circumstances where a physician deems the potential benefits outweigh the known hazards to the mother's life. Always seek medical advice before use.
Breast feedingUNSAFE
Administering Celcarb 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Celcarb 150mg Injection might reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
Patients with impaired kidney function should use Celcarb 150mg Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Kidney function should be regularly monitored during treatment with Celcarb 150mg Injection.
LiverSAFE IF PRESCRIBED
The use of Celcarb 150mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Celcarb 150mg Injection :
Should you forget a scheduled dose of the Celcarb 150mg injection, seek advice from your physician.
Facts to Know About Celcarb 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Class | Platinum-based anticancer agents |
3,018 People bought this recently